Assessing angiogenesis-regulating markers, including VASH1, VASH2, and iNOS, in circulating WBCs provides deeper insights into the tumor microenvironment and immune response in HNSCC, surpassing the limitations of plasma measurements alone. Here, NOS2 is linked to head and neck squamous cell carcinoma.